Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01686360 · ClinicalTrials.gov registry record · NA
Communicating Objective Risk for Personalized Decision Making About Mammography
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,560
- Enrollment target
NCT01686360: Completed NA study, sponsored by University of Pennsylvania.
NCT01686360 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,560 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01686360, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,560 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of objective risk information about breast cancer and mammography outcomes using a randomized control trial. Women between the ages of 35 and 49 will receive information about their personal risk for breast cancer and be randomly assigned to receive data about a woman who should be screened, data about the potential outcomes of screening, or data about breast cancer deaths. Two presentation formats will be tested and compared.
Interventions
- BEHAVIORAL Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,560 participants |
| Start Date | 2012-09 |
| Est. Completion | 2012-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01686360
The ClinicalTrials.gov registry entry for NCT01686360 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,560 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision Aid is the first listed.
NCT01686360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01686360 about?
NCT01686360 is a clinical study titled "Communicating Objective Risk for Personalized Decision Making About Mammography". The purpose of this study is to test the effects of objective risk information about breast cancer and mammography outcomes using a randomized control trial. Women between the ages of 35 and 49 will receive information about their personal risk for breast cancer and be randomly assigned to receive d...
What is the current status of trial NCT01686360?
This trial is currently completed. It is a NA study. The enrollment target is 1,560 participants. The study started on 2012-09. Estimated completion is 2012-12-18.
What interventions are being tested in trial NCT01686360?
The interventions under investigation include: Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT01686360?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.